In Treatment

VIDEOS

This is the third batch of videos from the Blood Cancer OncTalk playlist. In these videos, Dr. Alankrita Taneja defines Smoldering Multiple Myeloma...

This is the third batch of videos from the Blood Cancer OncTalk playlist. In these videos, Dr. Sridevi Rajeeve gives a brief description of multiple...

This is the third batch of videos from the Blood Cancer OncTalk playlist. In these videos, Dr. Sridevi Rajeeve gives a brief description of multiple...

This is the second batch of videos from the Blood Cancer OncTalk playlist. In these videos, Dr. Marco Ruiz explains the concept of bone marrow...

This is the first batch of videos from the Blood Cancer OncTalk playlist. In these videos, Dr. Tycel Phillips discusses Bispecific Antibody Treatment...

ARTICLES

Applications are now open to oncology fellows and finishing fellows Program Information Form and Application Patient Education Ambassadors Program...

COMMUNITY FORUM

Lesion?

It's exciting to see such PFS numbers for advanced NSCLC. From ASCO Daily News, Benefit With Lorlatinib in Advanced ALK-Positive NSCLC Key Points: At...

Hello everyone, my father has stage 4 NSCLC ROS1 +, he started Crizotinib treatment 2 weeks ago. Pleural effusion was observed in his lung during...

Hi all - I’m not sure how I’ve gotten here but I fell down a rabbit hole and here I am. I’m 65yr old male non smoker. I was diagnosed with a very rare...

Hello everyone, I have worried myself sick thinking that I have a Pancoast tumor/ am in the early stages, thanks to Google. Any help would be greatly...

Recent Comments

Thanks for the information…
Comment By JanineT GRACE … on Jan 29, 2025 10:22 am
Thanks for the information…
Comment By JanineT GRACE … on Jan 29, 2025 10:22 am
Tagrisso side effects?
Comment By JanineT GRACE … on Jan 29, 2025 10:22 am
Tagrisso side effects?
Comment By JanineT GRACE … on Jan 29, 2025 10:22 am

Targeted Therapies Forum Presented in English 2023 - Breakout Sessions 2

Video

This series includes videos from the breakout sessions presented by Dr. Stephen Liu, including the following topics:

  • Safety and Toxicity of Selpercatinib Versus Pralsetinib
  • The Future of RET+ NSCLC Treatment
  • NTRK+ NSCLC: Treatment Options and Side Effects
  • NRG1 Fusions: Treatment Options

To watch the complete playlist click here.

Targeted Therapies Forum Presented in English 2023 - Breakout Sessions

Video

This series includes videos from the breakout sessions presented by Dr. Stephen Liu and Dr. Misako Nagasaka, including the following topics:

  • Treatments and Study Data for Patients with ALK+ NSCLC
  • Treatment Options & Study Data for Patients with ROS1+ NSCLC
  • Rare Fusions in NSCLC: RET
  • RET Fusion Treatment: Selpercatinib
  • RET Fusion Treatment: Pralsetinib

To watch the complete playlist click here.

Multiple EGFR mutation lung cancer

Dear GRACE, In 2020, my mom was diagnosed with right lung adenocarcinoma, which led to her undergoing surgery. Unfortunately, the cancer had spread to her left lung by 2021, requiring another surgery followed by four cycles of chemotherapy. Both instances of the cancer were identified as having the EGFR exon 21 L858R mutation. In April 2022, a new development occurred as the cancer metastasized to her right clavicular lymph node. To address this, she was prescribed Tagrisso for three months. However, the response to this treatment was not as favorable as we had hoped.
wei sun
Subscribe to In Treatment